Michael E. O'Dwyer

National University of Ireland Galway

Ireland

Research Interests

Explore related searches

Professors in Ireland Professors in Immunology Immunology professors in Ireland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (12)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2021

Collaborators (11)

Eric Vivier

Chief Science Officer

FRANCE

View details

Mattias Carlsten

Karolinska Institutet

SWEDEN

View details

Siobhan Glavey

Royal College of Surgeons in Ireland

IRELAND

View details

Triona Ni Chonghaile

Senior Lecturer

Royal College of Surgeons in Ireland

IRELAND

View details

Roman Hajek

University of Ostrava

CZECH REPUBLIC

View details

Alessandro Natoni

Sapienza University

ITALY

View details

Robert Orlowski

Florence Maude Thomas Cancer Research Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Eva Szegezdi

Senior Lecturer in Biochemistry

National University of Ireland Galway

IRELAND

View details

Saad Usmani

Chief Attending

Memorial Sloan Kettering Cancer Center

UNITED STATES

View details

Nicholas Riley

Assistant Professor

University of Washington

UNITED STATES

View details

Nina Orfali

Trinity College Dublin, The University of Dublin

IRELAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Michael E. O'Dwyer

Research Interests

Explore related searches

Contact this professor

Articles (12)

Daratumumab/lenalidomide/dexamethasone in transplant-ineligible newly diagnosed myeloma: MAIA long-term outcomes

Daratumumab plus lenalidomide/dexamethasone in untreated multiple myeloma: analysis of key subgroups of the MAIA study

Steroid-free combination of 5-azacytidine and venetoclax for the treatment of multiple myeloma.

Consensus guidelines and recommendations for the management and response assessment of chimeric antigen receptor T-cell therapy in clinical practice for relapsed and refractory multiple myeloma: a report from the International Myeloma Working Group Immunotherapy Committee

Blood Cancer Network Ireland (BCNI) and National Cancer Registry Ireland (NCRI) collaboration: challenges and utility of an Enhanced Blood Cancer Outcomes Registry (EBCOR) pilot.

Natural killer cell biology and therapy in multiple myeloma: challenges and opportunities.

Hypersialylation and multiple myeloma

NK cell line modified to express a potent, DR5 specific variant of TRAIL, show enhanced cytotoxicity in ovarian cancer models

PSGL-1 decorated with sialyl Lewis<sup>a/x</sup> promotes high affinity binding of myeloma cells to P-selectin but is dispensable for E-selectin engagement

Adoptive Immunotherapy and High-Risk Myeloma.

Targeting hypersialylation in multiple myeloma represents a novel approach to enhance NK cell–mediated tumor responses

Realizing Innate Potential: CAR-NK Cell Therapies for Acute Myeloid Leukemia

Collaborators (11)

Eric Vivier

Mattias Carlsten

Siobhan Glavey

Triona Ni Chonghaile

Roman Hajek

Alessandro Natoni

Robert Orlowski

Eva Szegezdi

Saad Usmani

Nicholas Riley

Nina Orfali

Make your next move.